CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-. Cytokine Signature

被引:2
|
作者
Srinagesh, Hrishikesh [1 ]
Baird, John H. [2 ]
Agarwal, Neha [1 ]
Su, Yi-Jiun [1 ]
Kramer, Anne Marijn [3 ]
Reschke, Agnes [1 ]
Jeyakumar, Nikeshan [1 ]
Bharadwaj, Sushma [1 ]
Schultz, Liora Michal [4 ]
Ramakrishna, Sneha [5 ]
Davis, Kara L. [6 ]
Sahaf, Bita [7 ]
Feldman, Steven [3 ]
Mackall, Crystal L. [8 ]
Miklos, David B. [9 ]
Muffly, Lori S. [1 ]
Frank, Matthew J. [9 ]
机构
[1] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Sch Med, Palo Alto, CA USA
[2] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA USA
[3] Stanford Univ, Ctr Canc Cell Therapy, Stanford, CA USA
[4] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[5] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[6] Stanford Univ, Dept Pediat Hematol Oncol & Stem Cell Transplant, Stanford, CA USA
[7] Stanford Univ, Canc Correlat Sci Unit, Palo Alto, CA USA
[8] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA USA
[9] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Palo Alto, CA USA
关键词
D O I
10.1182/blood-2023-178283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [21] A CD8+ T Cell-Related Genes Expression Signature Predicts Prognosis and the Efficacy of Immunotherapy in Breast Cancer
    Lian-hua Lv
    Jia-rong Lu
    Tao Zhao
    Jing-li Liu
    Hai-qi Liang
    Journal of Mammary Gland Biology and Neoplasia, 2022, 27 : 53 - 65
  • [22] A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer
    Fei Lin
    Zhi-Bin Ke
    Yu-Ting Xue
    Jia-Yin Chen
    Hai Cai
    Yun-Zhi Lin
    Xiao-Dong Li
    Yong Wei
    Xue-Yi Xue
    Ning Xu
    Inflammation Research, 2023, 72 : 1665 - 1687
  • [23] A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer
    Lin, Fei
    Ke, Zhi-Bin
    Xue, Yu-Ting
    Chen, Jia-Yin
    Cai, Hai
    Lin, Yun-Zhi
    Li, Xiao-Dong
    Wei, Yong
    Xue, Xue-Yi
    Xu, Ning
    INFLAMMATION RESEARCH, 2023, 72 (08) : 1665 - 1687
  • [24] A CD8+ T Cell-Related Genes Expression Signature Predicts Prognosis and the Efficacy of Immunotherapy in Breast Cancer
    Lv, Lian-Hua
    Lu, Jia-Rong
    Zhao, Tao
    Liu, Jing-Li
    Liang, Hai-Qi
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2022, 27 (01) : 53 - 65
  • [25] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [26] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2020, 136
  • [27] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [28] T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma
    Wang, Jiachen
    Shen, Kefeng
    Mu, Wei
    Li, Weigang
    Zhang, Meilan
    Zhang, Wei
    Li, Zhe
    Ge, Tong
    Zhu, Zhoujie
    Zhang, Shangkun
    Chen, Caixia
    Xing, Shugang
    Zhu, Li
    Chen, Liting
    Wang, Na
    Huang, Liang
    Li, Dengju
    Xiao, Min
    Zhou, Jianfeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023
    Li, Huimin
    Huang, Qing
    Zhang, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [30] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138